|
WO2020223118A1
|
|
Multiplex shrna for use in vectors
|
|
EP2764123A1
|
|
Optimization of vectors for effective delivery and expression of genetic content
|
|
WO2013043442A1
|
|
The introduction of modular vector elements during production of a lentivirus
|
|
WO2012015775A2
|
|
Sirna targeting vegfa and methods for treatment in vivo
|
|
JP2010172344A
|
|
Modified polynucleotide for use in rna interference
|
|
US2010113307A1
|
|
siRNA targeting vascular endothelial growth factor (VEGF)
|
|
US2010048425A1
|
|
siRNA targeting tumor protein 53 (p53)
|
|
US2009280567A1
|
|
Stabilized sirnas as transfection controls and silencing reagents
|
|
US2009281297A1
|
|
siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)
|
|
US2009227780A1
|
|
siRNA targeting connexin 43
|
|
US2009306356A1
|
|
siRNA targeting TNFα
|
|
WO2009023525A2
|
|
Methods of modulating mesenchymal stem cell differentiation
|
|
US2010273856A1
|
|
Screening of micro-RNA cluster inhibitor pools
|
|
WO2009012173A2
|
|
Enhanced biotherapeutic production using inhibitory rna
|
|
US2009118489A1
|
|
siRNA targeting nucleoporin 62kDa (Nup62)
|
|
US2009069265A1
|
|
siRNA targeting inner centromere protein antigens (INCENP)
|
|
US2008268457A1
|
|
siRNA targeting forkhead box P3 (FOXP3)
|
|
EP2155911A1
|
|
Micro-RNA scaffolds, non-naturally occurring micro-RNAs, and methods for optimizing non-naturally occurring micro-RNAs
|
|
WO2008144472A1
|
|
Novel chromophoric silyl protecting groups and their use in the chemical synthesis of oligonucleotides
|
|
US2008177051A1
|
|
siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
|
